The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19 | Zendy

Demet Yalçın Kehribar | Zendy; Mustafa Cihangiroğlu | Zendy; Emine Sehmen | Zendy; Bahattin Avcı | Zendy; Mustafa ÇAPRAZ | Zendy; Maruf Boran | Zendy; Caner GÜNAYDIN | Zendy; Metin Özgen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19

Author(s) -

Demet Yalçın Kehribar,

Mustafa Cihangiroğlu,

Emine Sehmen,

Bahattin Avcı,

Mustafa ÇAPRAZ,

Maruf Boran,

Caner GÜNAYDIN,

Metin Özgen

Publication year - 2020

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2006-96

Subject(s) - medicine , covid-19 , virology , outbreak , disease , infectious disease (medical specialty)

It is claimed that aberrant immune response has a more important role than the cytopathic effect of the virus in the morbidity and mortality of the coronavirus disease 2019 (COVID-19). We aimed to investigate the possible roles of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 pathway and leukotrienes (LT) in uncontrolled immune response that occurs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research